Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00154141 · ClinicalTrials.gov registry record · Phase 3
Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures
A Phase 3 study, sponsored by Ethicon.
- Completed
- Registry status
- Phase 3
- Development phase
- 150
- Enrollment target
NCT00154141 is a Phase 3 study that has completed, run by Ethicon. The registered enrollment target is 150 participants.
The verdict
NCT00154141, a Phase 3 study, has completed, sponsored by Ethicon.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 150 participants
- Enrollment target
Study Summary
A comparison of a fibrin sealant versus manual compression in stopping surgical bleeding during vascular procedures.
Interventions
- DRUG Fibrin sealant (FS2)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2005-06 |
| Est. Completion | 2006-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00154141
The ClinicalTrials.gov registry entry for NCT00154141 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ethicon, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fibrin sealant (FS2) is the first listed.
NCT00154141 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00154141 about?
NCT00154141 is a clinical study titled "Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures". A comparison of a fibrin sealant versus manual compression in stopping surgical bleeding during vascular procedures.
What is the current status of trial NCT00154141?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 150 participants. The study started on 2005-06. Estimated completion is 2006-03.
What interventions are being tested in trial NCT00154141?
The interventions under investigation include: Fibrin sealant (FS2) (DRUG).
Who is sponsoring clinical trial NCT00154141?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.